Zobrazeno 1 - 10
of 202
pro vyhledávání: '"Rafael, Duran"'
Autor:
Guillaume Gravel, Florent Artru, Miriam Gonzalez-Quevedo, Georgia Tsoumakidou, Nicolas Villard, Rafael Duran, Alban Denys
Publikováno v:
CVIR Endovascular, Vol 7, Iss 1, Pp 1-7 (2024)
Abstract Purpose Even though transjugular intrahepatic portosystemic shunt (TIPS) using Fluency Stent-grafts provides good shunt patency rates, shunt dysfunction is a great concern after TIPS creation, occurring in up to 20% of cases within one year.
Externí odkaz:
https://doaj.org/article/2b36c7285d454f27a36b242940ef3385
Autor:
Flavian Tabotta, Silvano Gnesin, Vincent Dunet, Alexandre Ponti, Antonia Digklia, Sarah Boughdad, Niklaus Schaefer, John O. Prior, Nicolas Villard, Georgia Tsoumakidou, Alban Denys, Rafael Duran
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-13 (2023)
Abstract First-line selective internal radiation therapy (SIRT) showed promising outcomes in patients with uveal melanoma liver metastases (UMLM). Patient survival depends on liver’s disease control. SIRT planning is essential and little is known a
Externí odkaz:
https://doaj.org/article/ec74a5a5a2104c99b822d94ea65d30f5
Publikováno v:
Frontiers in Pediatrics, Vol 12 (2024)
Fontan physiology creates a chronic state of decreased cardiac output and systemic venous congestion, leading to liver cirrhosis/malignancy, protein-losing enteropathy, chylothorax, or plastic bronchitis. Creating a fenestration improves cardiac outp
Externí odkaz:
https://doaj.org/article/ab61b9c6dcd140568f0ef9bd03db7b73
Autor:
Bello, Abiodun *, Giménez-Rico, Rafael Durán, Gilani, Saad, Hillen, Bart C., Venter, Kyle M., Plumstead, Peter, Dersjant-Li, Yueming
Publikováno v:
In Poultry Science December 2023 102(12)
Autor:
Petrovic, Marija, Tankov, Stoyan, Kiening, Martin, Chakradhar, Yakkala, Rafael, Duran, Walker, Paul R., Borchard, Gerrit, Jordan, Olivier
Publikováno v:
In OpenNano July 2023 12
Autor:
Antonia M. Berz, Sarah Boughdad, Naïk Vietti-Violi, Antonia Digklia, Clarisse Dromain, Vincent Dunet, Rafael Duran
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
In recent years, a wide range of cancer immunotherapies have been developed and have become increasingly important in cancer treatment across multiple oncologic diseases. In particular, immune checkpoint inhibitors (ICIs) offer promising options to i
Externí odkaz:
https://doaj.org/article/b42a6d1d2066411d9d0d0a7b1b3c684c
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
In recent years, various systemic immunotherapies have been developed for cancer treatment, such as monoclonal antibodies (mABs) directed against immune checkpoints (immune checkpoint inhibitors, ICIs), oncolytic viruses, cytokines, cancer vaccines,
Externí odkaz:
https://doaj.org/article/0406dc0da0f04b48bcadabf07ed05a3d
Autor:
Florent Artru, Naik Vietti-Violi, Christine Sempoux, Joana Vieira Barbosa, Fabio Becce, Nelly Sah, Astrid Marot, Pierre Deltenre, Eleni Moschouri, Montserrat Fraga, Arnaud Hocquelet, Rafael Duran, Darius Moradpour, Pierre-Emmanuel Rautou, Alban Denys
Publikováno v:
JHEP Reports, Vol 4, Iss 8, Pp 100511- (2022)
Background & Aims: We aimed to evaluate long-term outcome of patients with chronic non-cirrhotic extrahepatic portal vein obstruction (CNC-EHPVO) who underwent portal vein recanalisation (PVR) without transjugular intrahepatic portosystemic shunt (TI
Externí odkaz:
https://doaj.org/article/98b069543dd249a4a7c730dcccaceaef
Autor:
Roberto Cannella, Lambros Tselikas, Fréderic Douane, François Cauchy, Pierre-Emmanuel Rautou, Rafael Duran, Maxime Ronot
Publikováno v:
JHEP Reports, Vol 4, Iss 7, Pp 100484- (2022)
Summary: Portal hypertension is defined by an increase in the portosystemic venous gradient. In most cases, increased resistance to portal blood flow is the initial cause of elevated portal pressure. More than 90% of cases of portal hypertension are
Externí odkaz:
https://doaj.org/article/c820750b19ca4ad7b9b84c780378638b
Autor:
Irvin Rexha, Fabian Laage-Gaupp, Julius Chapiro, Milena Anna Miszczuk, Johanna Maria Mijntje van Breugel, MingDe Lin, Menelaos Konstantinidis, Rafael Duran, Bernhard Gebauer, Christos Georgiades, Kelvin Hong, Nariman Nezami
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract This study was designed to assess 3D vs. 1D and 2D quantitative tumor analysis for prediction of overall survival (OS) in patients with Intrahepatic Cholangiocarcinoma (ICC) who underwent conventional transarterial chemoembolization (cTACE).
Externí odkaz:
https://doaj.org/article/cc6d0d3c30ec4a84b352388775280341